CHEK1 and central nervous system cancer: Previous studies have demonstrated that Onalespib significantly impairs DNA repair by depleting homologous recombination (HR) proteins such as CHK1 and RAD51, reducing HR repair and increasing glioma stem cell sensitivity to radiation and TMZ (15).